Four Pensacola Women Charged with Illegal Drug Diversion
PENSACOLA, FLA. – Today, United States Attorney John P. Heekin announced criminal charges against four defendants with an alleged scheme to unlawfully divert oxycodone, hydrocodone, and amphetamine. The charges filed in federal court are part of the Department of Justice’s 2025 National Health Care Fraud Takedown.
All the cases are part of a strategically coordinated, nationwide law enforcement action that resulted in criminal charges against 324 defendants for their alleged participation in healthcare fraud and illegal drug diversion schemes involving the submission of more than $14.6 billion in intended loss and over 15 million pills of illegally diverted controlled substances. The defendants allegedly defrauded programs entrusted for the care of the elderly and disabled to line their own pockets. The United States has seized more than $245 million in cash, luxury vehicles and other assets in connection with the takedown.
The following individuals were charged in the Northern District of Florida: Alexandra M. Christensen, 31; Lindsay N. McCray, aka Lindsay Rogers, 41; Heather T. Bradley, aka Heather Thomas, 36; and Jennifer E. Purves, 39, all of Pensacola, Fla.
According to court records, Christensen and McCray were charged with conspiracy to distribute and dispense controlled substances. McCray, Bradley, and Purves are charged with distribution of controlled substances, and McCray is charged with identity theft in connection with a scheme to unlawfully divert oxycodone, hydrocodone, and amphetamine. As alleged in the indictment, between 2015 and 2024, McCray, while employed by a medical practice, forged controlled substance prescriptions using the names, signatures, and Drug Enforcement Administration registration numbers of the practice’s two physicians without their knowledge or authorization. As a result of the conspiracy, McCray, Christensen, and others caused to be unlawfully distributed and dispensed over 300,000 hydrocodone pills and over 30,000 oxycodone pills. McCray is further charged with distributing and aiding and abetting the distribution of amphetamine with Bradley and Purves. The Health Care Fraud Unit’s Data Analytics Team used cutting-edge data analytics to identify and support the investigations that led to these charges.
Trial for all defendants is currently set for August 18, 2025, at 9 a.m. before United States District Judge T. Kent Wetherell II. If convicted, McCray faces a maximum of 80 years’ imprisonment, and Christensen, Bradley, and Purves each face up to 20 years’ imprisonment.
The Northern District of Florida, in particular, worked with the following law enforcement organizations to investigate and prosecute the cases filed during the enforcement period: Drug Enforcement Administration; Drug Enforcement Administration's Diversion Control Division; Santa Rosa County Sheriff’s Office; Escambia County Sheriff’s Office; Florida Department of Law Enforcement; and Gulf Coast High Intensity Drug Trafficking Areas Task Force. The case is being prosecuted by the U.S. Attorney's office for the Northern District of Florida.
An indictment is merely an allegation by a grand jury that a defendant has committed a violation of federal criminal law and is not evidence of guilt. All defendants are presumed innocent and entitled to a fair trial, during which it will be the government’s burden to prove guilt beyond a reasonable doubt at trial.
